Why AstraZeneca Stock Topped the Market on Tuesday

Newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company's stock market listing onto our shores (ADSes are certificates conferring ownership of a stock, not the stock itself)

Image source: Getty Images

Citing unidentified multiple sources, the newspaper wrote that Soriot might also be mulling a move of AstraZeneca's headquarters from the U

According to The Times' reporting, the chief executive is "known to be deeply frustrated with the U. 's operating environment. " The newspaper added that he has publicly expressed concern what he perceives to be a decline in European competitiveness against the U

The pair happens to be the company's two largest

Neither Soriot nor AstraZeneca has yet officially ed on the article

Land of opportunity Since AstraZeneca has quite a presence in the U

Healthcare market and does much of its in the country, it makes abundant sense to shift the main stock market listing and even the headquarters here

It's un (at least for now) how much this might affect the company's fundamentals and operations, but as a concept, it's a good idea

Eric Volkman has no position in any of the stocks mentioned

The Motley Fool recommends AstraZeneca Plc

The Motley Fool has a disclosure policy.